| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |